Table 4.
Pregnancy rate and OHSS rate for hMG versus r-hFSH
| Studied endpoint for hMG versus r-hFSH | RR | 95% CI | p value | RD | 95% CI | P value |
|---|---|---|---|---|---|---|
| Pregnancy rate | ||||||
| - Main analysis | 1.10 | 0.97, 1.25 | 0.06 | 0.03 | -0.01, 0.07 | 0.051 |
| - Sub-group 1 | 1.09 | 0.95, 1.24 | 0.10 | 0.03 | -0.01, 0.07 | 0.08 |
| - Sub-group 2 | 1.09 | 0.95, 1.26 | 0.12 | 0.03 | -0.01, 0.07 | 0.08 |
| Pregnancy rate adjusted for baseline | 1.04 | 0.89, 1.15 | 0.49 | 0.01 | -0.02, 0.04 | 0.34 |
| OHSS | ||||||
| - Main analysis | 1.47 | 0.91, 2.39 | 0.12 | 0.02 | -0.00, 0.04 | 0.72 |
| - Sub-group 1 | 1.40 | 0.84, 2.36 | 0.20 | 0.01 | -0.00, 0.03 | 0.65 |
| - Sub-group 2 | 1.40 | 0.84, 2.34 | 0.20 | 0.01 | -0.00, 0.03 | 0.62 |
hMG = human menopausal gonadotrophins; r-hFSH = recombinant human follicle-stimulating hormone; OHSS = ovarian hyperstimulation syndrome; RR = relative risk; RD = absolute risk difference